8 results
10-K
2021 FY
RLYB
Rallybio Corp
15 Mar 22
Annual report
4:31pm
expectant mothers of any race or ethnicity who are at high risk of FNAIT are identified and eligible for treatment. To this end, we initiated a FNAIT
8-K
EX-99.1
RLYB
Rallybio Corp
7 Mar 22
MARCH 2022 TAKING A DEVASTATING DISEASE – AND DEVASTATING IT. We’re going there. Corporate Presentation
8:00am
expectant mothers of any race or ethnicity who are at high risk of FNAIT are identified and eligible for treatment FNAIT natural history study
424B4
RLYB
Rallybio Corp
30 Jul 21
Prospectus supplement with pricing info
8:28am
or ethnicity who are at high risk of FNAIT are identified and eligible for treatment. We intend to initiate a natural history study of FNAIT in the third
S-1/A
RLYB
Rallybio Corp
22 Jul 21
IPO registration (amended)
4:04pm
to ensuring that all expectant mothers of any race or ethnicity who are at high risk of FNAIT are identified and eligible for treatment. We intend
S-1
n4oqsbnvgujb 285
2 Jul 21
IPO registration
4:28pm
DRS/A
lpcbb yar9
7 Jun 21
Draft registration statement (amended)
12:00am
DRS
zlc o19zu061ib
27 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next